Acute Treatment Of stroke

Tissue plasminogen activator (t-PA) was demonstrated to be effective in the first 3 hours after acute ischemic stroke in a pivotal randomized clinical trial sponsored by the National Institutes of Neurological Disorders and Stroke NINDS.